Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genzyme, a Sanofi Company
The total study duration for a patient is approximately 47 months.
There is no administration of GZ402668 in the LTS14120 study. Patients who already received investigational medicinal product (GZ402668 or placebo) in TDU13475 or TDU14981 will be followed up to 47 months in the LTS14120.
Note: Patients from TDU14981 study (sanofi-sponsored) will participate in LTS14120 study. In order to keep consistent among all study related documents, the title of the LTS14120 study is not amended.
Age
18–66
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Received investigational medicinal product (GZ402668 or placebo) in TDU13475 or TDU14981
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
